Related references
Note: Only part of the references are listed.Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis
V. Ramesh et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Recent advances in post-kala-azar dermal leishmaniasis
Dinesh Mondal et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Post-Kala-azar Dermal Leishmaniasis in Nepal: A Retrospective Cohort Study (2000-2010)
Surendra Uranw et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Increasing Incidence of Post-Kala-Azar Dermal Leishmaniasis in a Population-Based Study in Bangladesh
Kazi Mizanur Rahman et al.
CLINICAL INFECTIOUS DISEASES (2010)
Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh
Dinesh Mondal et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Host peroxisomal properties are not restored to normal after treatment of visceral leishmaniasis with sodium antimony gluconate
Shreedhara Gupta et al.
EXPERIMENTAL PARASITOLOGY (2009)
Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy
Dinesh Mondal et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Hypopigmented post-kala-azar dermal leishmaniasis
V. Ramesh et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2008)
Immunochemotherapy of persistent post-kata-azar dermal leishmaniasis: a novel approach to treatment
Ahmed Mudawi Musa et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Efficacy of liposomal amphotericin B (AmBisome®) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)
AM Musa et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2005)
Post-kala-azar dermal leishmaniasis
EE Zijistra et al.
LANCET INFECTIOUS DISEASES (2003)
Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods
P Salotra et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features
AM Musa et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2002)
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome
K Ritmeijer et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Post-kala-azar dermal leishmaniasis:: does it play a role in the transmission of Leishmania donovani in the Sudan?
AM El Hassan et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis
P Salotra et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Post-kala-azar dermal leishmaniasis in Nepal
VK Garg et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2001)
Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis
EE Zijlstra et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC)
S Gasim et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
